AMDL Signs MOU for 200 Store Distribution Arrangements for Goodnak Product Line
April 30 2008 - 10:00AM
PR Newswire (US)
TUSTIN, Calif., April 30 /PRNewswire-FirstCall/ -- AMDL, Inc.
(AMEX:ADL), headquartered in Tustin, California, with operations in
Shenzhen, Jiangxi, and Jilin, China, is a vertically integrated
specialty pharmaceutical company. In combination with its
subsidiary Jade Pharmaceutical Inc., (JPI), the Company engages in
the research, development, manufacturing, and marketing of
diagnostic, pharmaceutical, nutritional supplement, and cosmetic
products. AMDL today announced that JPI has signed a Memorandum of
Understanding (MOU) with Zhejiang HuaDu Beauty Co. Ltd. HuaDu owns
more than 200 beauty stores and a beauty care training school
located in Zhejiang province. The MOU creates a path for HuaDu to
sell JPI's Goodnak anti-aging product and a new to-be-launched set
of seven new Goodnak non-injectable anti-aging human products.
These seven new Goodnak products are anticipated to be marketed
during the second and third quarters of 2008. JPI also recently
held a conference in the city of Hangzhou to discuss with various
beauty salon operators and regional hospitals the development of
JPGREEN Anti-Aging Clinics. These clinics would be developed
primarily through the conversion of existing operations into
JPGREEN Anti-Aging Clinics locations. It is anticipated that a
minimum of 100 JPGREEN Anti-Aging Clinics and at least 13 Hospital
operated therapeutic anti-aging clinics would be developed over the
next 12 months. Mr. Gary Dreher, CEO of AMDL, noted that "our new
JPGREEN Anti-Aging Clinics concept appears to be the most prudent
path to developing and expanding this important area of JPI's
business." About Jade Pharmaceutical: JPI has access to the fastest
growing pharmaceutical and consumer market in the world: China.
AMDL, through its subsidiaries, JPI currently manufactures large
volume injection fluids, tablets and other related products,
holding licenses for 133 products. It also manufactures 107
generic, over the counter and supplemental pharmaceutical products
under certified Chinese Good Manufacturing Practice (CGMP)
standards. Forward-Looking Statements This news release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such statements are
subject to certain risks and uncertainties, and actual
circumstances, events or results may differ materially from those
projected in such forward-looking statements. The Company cautions
readers not to place undue reliance on any forward-looking
statements. The Company does not undertake, and specifically
disclaims any obligation, to update or revise such statements to
reflect new circumstances or unanticipated events as they occur.
About AMDL: More information about AMDL and its products can be
obtained at http://www.amdl.com/. Contact: AMDL, Inc. Mr. Paul
Knopick AMDL Investor Relations Direct Line: 949.707.5365 Voice
Mail: 714.505.4460 DATASOURCE: AMDL, Inc. CONTACT: Mr. Paul
Knopick, AMDL Investor Relations, +1-949-707-5365, Voice Mail,
+1-714-505-4460
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jul 2023 to Jul 2024